The Valsartan Recall May Shake Up ARB Use at Your Hospital

The valsartan recall will continue to raise questions.

Several generic valsartan products and their combos with hydrochlorothiazide and amlodipine are recalled...but not the combo with sacubitril (Entresto).

The recalled products may have been contaminated with the probable carcinogen N-nitrosodimethylamine (NDMA) for as long as 4 years...possibly because of changes in how valsartan was made.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals